Education
About Us
Working with TipRanks
Follow Us
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 37.00K | $ 20.72M | $ 3.13M | $ 18.04M | $ 13.61M |
| Gross Profit | $ 37.00K | $ -76.37M | $ -751.00K | $ 15.02M | $ -39.43M |
| Operating Income | $ -187.84M | $ -112.87M | $ -110.03M | $ -71.33M | $ -56.66M |
| EBITDA | $ -187.84M | $ -107.12M | $ -106.15M | $ -68.31M | $ -55.22M |
| Net Income | $ -160.87M | $ -100.84M | $ -101.08M | $ -68.30M | $ -56.54M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 424.88M | $ 288.23M | $ 218.64M | $ 315.43M | $ 276.73M |
| Total Assets | $ 560.38M | $ 339.89M | $ 261.85M | $ 353.49M | $ 288.33M |
| Total Debt | $ 24.61M | $ 14.67M | $ 16.12M | $ 16.45M | $ 0.00 |
| Net Debt | $ -124.73M | $ -234.44M | $ -202.52M | $ -298.98M | $ -276.73M |
| Total Liabilities | $ 49.78M | $ 32.06M | $ 30.51M | $ 560.48M | $ 31.94M |
| Stockholders' Equity | $ 510.61M | $ 307.83M | $ -314.49M | $ -207.00M | $ 256.39M |
| Cash Flow | |||||
| Free Cash Flow | $ -134.59M | $ -78.56M | $ -98.22M | $ -78.24M | $ -51.91M |
| Operating Cash Flow | $ -134.59M | $ -75.79M | $ -86.69M | $ -69.13M | $ -50.91M |
| Investing Cash Flow | $ -302.44M | $ 115.72M | $ -17.05M | $ -172.68M | $ -1.00M |
| Financing Cash Flow | $ 337.25M | $ 156.83M | $ 3.08M | $ 118.09M | $ 278.98M |